secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGM Biosciences, Inc. (—)
CIK:        0001496323
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0000950170-25-084924
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

IGM Biosciences receives Nasdaq non-compliance notice for MVLS below $50M
-------------------------------------------------------------------------

- Received Nasdaq notice on June 6, 2025, for MVLS below $50M minimum requirement.
- Has 180 calendar days, until December 3, 2025, to regain compliance.
- Must have MVLS close at $50M+ for 10 consecutive business days to cure.
- If non-compliance persists, Nasdaq may initiate delisting; company can appeal or consider transfer to Nasdaq Capital Market.
- Listing continues under 'IGMS' with no immediate effect on trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1496323/000095017025084924/0000950170-25-084924-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1496323/000095017025084924/igms-20250606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-084924

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer